Form 4 for RPRX Royalty Pharma plc
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-05 · accession 0001838139-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-11-07 | 2025-11-07 | RPRX | Urist Marshall | EVP, Research, Investments | C - Cnv Deriv | $0.00 | +160.0K | 206.7K | +343% | $0 |
| D | 2025-11-07 | 2025-11-05 | RPRX | Urist Marshall | EVP, Research, Investments | A - Grant | $0.00 | +4,626 | 43.9K | +12% | $0 |
| DI | 2025-11-07 | 2025-11-07 | RPRX | Urist Marshall | EVP, Research, Investments | C - Cnv Deriv | $0.00 | -16.0K | 247.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2025-11-07 | C | A | 160,000 | $0.00 | 206,667 | I | — | — | |
| 2 | Common | Class A Ordinary Shares | 2025-11-05 | A | A | 4,626 | $0.00 | 43,882 | D By Sandy Lamm LLC | — | — | (F1) Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards. |
| 3 | Derivative | LP interests in RPI US Partners 2019, LP | 2025-11-07 | C | D | 16,000 | $0.00 | 247,412 | I By Sandy Lamm LLC | $0.00 · — to — | 160,000 Class A Ordinary Shares | (F3) Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value. |